Bristol-Myers: Drug combo cured hepatitis C in 97 percent of patients also infected with HIV

Drugmaker Bristol-Myers Squibb Co. said Thursday that an experimental combination of two hepatitis C drugs — its daclatasvir and Gilead Sciences Inc.'s blockbuster drug Sovaldi — cured hepatitis C in just 12 weeks in nearly all the patients, who also are infected with the HIV virus.



from RSSMix.com Mix ID 7907849 http://ift.tt/1BjkiII via gold ira